Clinical Scorecard: Glaucoma Group Therapy Video: Allo-Fail

At a Glance

Key Highlights

• AlloFlo Uveo superchoroidal device can initially reduce intraocular pressure in glaucoma patients.
• Cleft closure after device implantation can cause a significant spike in eye pressure.
• Tube shunt surgery may be required if device fails and patient consents to surgery.

Guideline-Based Recommendations

Diagnosis

• Monitor intraocular pressure closely after implantation of superchoroidal devices.
• Identify cleft closure as a cause of sudden pressure spikes.

Management

• Temporize elevated eye pressure conservatively if patient refuses surgery initially.
• Consider tube shunt surgery for pressure control if device fails and patient consents.

Monitoring & Follow-up

• Regular follow-up visits to assess intraocular pressure and device function, especially within first weeks post-implantation.

Risks

• Potential for cleft closure leading to massive intraocular pressure spikes.
• Failure of superchoroidal device requiring additional surgical intervention.

Patient & Prescribing Data

Glaucoma patients refusing incisional surgery

Superchoroidal device implantation may provide initial pressure control but requires close monitoring for complications; surgical options remain necessary if device fails.

Clinical Best Practices

• Educate patients on risks and benefits of superchoroidal devices versus incisional surgery.
• Maintain vigilant intraocular pressure monitoring post-implantation.
• Be prepared to escalate to surgical interventions such as tube shunts if device complications arise.
• Use a multidisciplinary approach including glaucoma specialists for complex cases.

References

• 2025 American Academy of Ophthalmology Meeting - Glaucoma Group Therapy Session